Interindividual changes in volume of distribution of cefazolin in newborn infants and its prediction based on physiological pharmacokinetic concepts

Yoshiharu Deguchi, Rie Koshida, Emi Nakashima, Reiji Watanabe, Noboru Taniguchi, Fujio Ichimura, Akira Tsuji

Research output: Contribution to journalArticle

18 Citations (Scopus)


The purpose of this study was to investigate factors affecting the volume of distribution of cefazolin (a β‐lactam antibiotic) in newborn infants with bacterial infections, and to propose a method for predicting the volume of distribution at steady state per body weight (Vdss/BW). Cefazolin and tobramycin (an aminoglycoside) were simultaneously given to newborn infants (aged 2 to 28 d), and plasma concentration‐time data were analyzed on the basis of model‐independent moment analysis. The Vdss/BW values ranged from 0.212 to 0.373 L/kg for cefazolin and from 0.384 to 0.541 L/kg for tobramycin. The unbound fraction of cefazolin in plasma (fp) fluctuated widely, from 0.22 to 0.83, among patients. The Vdss/BW value for cefazolin was characterized by both large extracellular water volume and a remarkable change in fp, and could be predicted as a function of fp using physiological pharmacokinetic concepts. Moreover, interindividual changes in the unconjugated bilirubin:albumin molar ratio were predominantly responsible for the individual variation in the fp values of cefazolin in newborn infants.

Original languageEnglish
Pages (from-to)674-678
Number of pages5
JournalJournal of Pharmaceutical Sciences
Issue number8
Publication statusPublished - 1988 Aug


ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this